JoshuaTolkienKantrowitzMD
Psychiatry • New York, NYAssociate Professor of Clinical Psychiatry at Columbia University
Dr. Kantrowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1051 Riverside Drive
New York State Psychiatric Institute
New York, NY 10032Phone+1 646-774-6738
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 2003 - 2007
State University of New York Downstate Medical Center College of MedicineClass of 2003
Certifications & Licensure
NY State Medical License 2007 - 2026
CT State Medical License 2005 - 2007- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Conversion to Antipsychotic Monotherapy Start of enrollment: 2007 Dec 01
- N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia Start of enrollment: 2012 Mar 01
- NMDA Antagonists in Bipolar Depression Start of enrollment: 2013 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsSchizoaffective disorder: a review of current research themes and pharmacological managementJoshua T. Kantrowitz, Leslie Citrome
CNS Drugs. 2011-04-01 - 309 citationsN-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?Joshua T. Kantrowitz, Daniel C. Javitt
Brain Research Bulletin. 2010-09-30 - 90 citationsNeural mechanisms of mismatch negativity dysfunction in schizophreniaMigyung Lee, Pejman Sehatpour, Matthew J. Hoptman, Peter Lakatos, Elisa C. Dias
Molecular Psychiatry. 2017-02-07
Journal Articles
- A Multicenter Study of Ketamine Effects on Functional Connectivity: Large Scale Network Relationships, Hubs and Symptom MechanismsRagy R Girgis, Richard J Maddock, John D Ragland, Daniel C Javitt, Cameron S Carter, Joshua T Kantrowitz, Jeffrey Lieberman, John H Krystal, Lawrence S Kegeles, Willia..., ScienceDirect
Press Mentions
Treatment of Tardive DyskinesiaAugust 13th, 2024- Karuna’s Experimental Schizophrenia Drug Succeeds in Advanced StudyAugust 8th, 2022
Some Caplyta Results in Schizophrenia Reach PrintJanuary 7th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
